Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody ; volume:16 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-13 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (12.9.2018), 1-13, 12.2018

Urheber
Kou, Jianqun
Beteiligte Personen und Organisationen
Musich, Phillip R.
Staal, Ben
Kang, Liang
Qin, Yuan
Yao, Zhi Q.
Zhang, Boheng
Wu, Weizhong
Tam, Angela
Huang, Alan
Hao, Huai-Xiang
Vande Woude, George F.
Xie, Qian
SpringerLink (Online service)

DOI
10.1186/s12967-018-1628-y
URN
urn:nbn:de:101:1-2018102819193927781408
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:58 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Kou, Jianqun
  • Musich, Phillip R.
  • Staal, Ben
  • Kang, Liang
  • Qin, Yuan
  • Yao, Zhi Q.
  • Zhang, Boheng
  • Wu, Weizhong
  • Tam, Angela
  • Huang, Alan
  • Hao, Huai-Xiang
  • Vande Woude, George F.
  • Xie, Qian
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering

Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering

MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping

MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells

In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells

A receptor-antibody hybrid hampering MET-driven metastatic spread

A receptor-antibody hybrid hampering MET-driven metastatic spread

Rückweisungen 1953 - 1979: Met - Met

Schriftgut

Rückweisungen 1953 - 1979: Met - Met

met

Graffiti | Streetart

met

Met

Graffiti | Streetart

Met

MEt'S

Graffiti | Streetart

MEt'S

"MET"

Graffiti | Streetart

"MET"

"Met"

Graffiti | Streetart

"Met"

Met

Kapitel

Met

Verbundene Objekte